Cargando…
Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566404/ https://www.ncbi.nlm.nih.gov/pubmed/34705164 http://dx.doi.org/10.1007/s40257-021-00642-3 |
| _version_ | 1784594003685015552 |
|---|---|
| author | Borg, Emma Thoning, Henrik |
| author_facet | Borg, Emma Thoning, Henrik |
| author_sort | Borg, Emma |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8566404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85664042021-11-15 Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study Borg, Emma Thoning, Henrik Am J Clin Dermatol Letter to the Editor Springer International Publishing 2021-10-27 2021 /pmc/articles/PMC8566404/ /pubmed/34705164 http://dx.doi.org/10.1007/s40257-021-00642-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter to the Editor Borg, Emma Thoning, Henrik Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study |
| title | Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study |
| title_full | Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study |
| title_fullStr | Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study |
| title_full_unstemmed | Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study |
| title_short | Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study |
| title_sort | comment on: drug survival of il‑12/23, il‑17 and il‑23 inhibitors for psoriasis treatment: a retrospective multi‑country, multicentric cohort study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566404/ https://www.ncbi.nlm.nih.gov/pubmed/34705164 http://dx.doi.org/10.1007/s40257-021-00642-3 |
| work_keys_str_mv | AT borgemma commentondrugsurvivalofil1223il17andil23inhibitorsforpsoriasistreatmentaretrospectivemulticountrymulticentriccohortstudy AT thoninghenrik commentondrugsurvivalofil1223il17andil23inhibitorsforpsoriasistreatmentaretrospectivemulticountrymulticentriccohortstudy |